Literature DB >> 23530300

ACE inhibitor and ARB medication use among Medicaid enrollees with diabetes.

Claudia M Lora1, Alexander W Sokolovsky, Daniel R Touchette, Jing Jin, Xiaojing Hu, Weihua Gao, Ben S Gerber.   

Abstract

OBJECTIVE: To examine ace-inhibitor (ACEI) and angiotensin receptor blockers (ARB) prescription and adherence patterns by race in diabetic public aid recipients. DESIGN, PARTICIPANTS, AND MEASURES: We analyzed prescription records of 27,529 adults aged 18-64 with diabetes who had at least one clinical indication for receiving an ACEI/ ARB prescription and were enrolled in the State of Illinois public aid program during 2007. We calculated proportion of days covered (PDC) to assess adherence. Multivariate models adjusted for age, sex, ACEI/ARB indication, and any significant interaction terms.
RESULTS: Only 47.4% of individuals with at least one indication for ACEI/ARB had filled an ACEI/ARB prescription. African American men were more likely than Caucasian men to ever fill an ACEI/ARB prescription (adjusted odds ratio, [AOR] [95% CI] 1.69 [1.55-1.83]). Hispanic English and Spanish speaking men were also more likely than Caucasian men to ever fill an ACEI/ARB prescription (AOR [95% CI] 1.37 [1.16-1.62] and 1.27 [1.05-1.53], respectively). Similarly, African American and Hispanic English and Spanish speaking women were more likely than Caucasian women to ever fill an ACEI/ARB prescription (AOR [95% CI] 1.70 [1.59-1.81], 1.55 (1.36-1.76), and 1.98 (1.73-2.28), respectively. However, African Americans and Hispanics were less likely than Caucasians to achieve a PDC> or =80%. Compared to Caucasians, Hispanic Spanish speakers were the least likely to be adherent (AOR [95% CI] .49 [.41-.58]). Furthermore, older individuals were more likely to achieve a PDC> or =80% than younger individuals.
CONCLUSION: African Americans and Hispanics with diabetes receiving public aid in Illinois were more likely than Caucasians to have filled at least one ACEI/ARB prescription. However, they were less adherent with these medications. Future studies should assess barriers to medication adherence in this population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23530300      PMCID: PMC3711220     

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  48 in total

1.  The association of race/socioeconomic status and use of Medicare services. A little-known failure in access to care.

Authors:  M E Gornick
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

2.  Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.

Authors:  S Andersen; L Tarnow; P Rossing; B V Hansen; H H Parving
Journal:  Kidney Int       Date:  2000-02       Impact factor: 10.612

3.  Racial/ethnic inequities in continuity and site of care: location, location, location.

Authors:  M P Doescher; B G Saver; K Fiscella; P Franks
Journal:  Health Serv Res       Date:  2001-12       Impact factor: 3.402

4.  Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data.

Authors: 
Journal:  Ann Intern Med       Date:  2001-03-06       Impact factor: 25.391

5.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

Authors:  H H Parving; H Lehnert; J Bröchner-Mortensen; R Gomis; S Andersen; P Arner
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

6.  Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.

Authors:  Y Lacourcière; A Bélanger; C Godin; J P Hallé; S Ross; N Wright; J Marion
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

Review 7.  Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review.

Authors:  Loes C Lanting; Inez M A Joung; Johan P Mackenbach; Steven W J Lamberts; Aart H Bootsma
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

8.  Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes.

Authors:  Allison B Rosen; Andrew J Karter; Jennifer Y Liu; Joe V Selby; Eric C Schneider
Journal:  J Gen Intern Med       Date:  2004-06       Impact factor: 5.128

9.  Ethnic differences in the treatment and control of hypertension in patients with diabetes.

Authors:  Jessica Flynn Riehle; Daniel T Lackland; Eni C Okonofua; Katherine H Hendrix; Brent M Egan
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-08       Impact factor: 3.738

10.  Racial and ethnic disparities in prescription coverage and medication use.

Authors:  Becky Briesacher; Rhona Limcangco; Darrell Gaskin
Journal:  Health Care Financ Rev       Date:  2003
View more
  2 in total

1.  Relationship Between Medication Adherence and Distance to Dispensing Pharmacies and Prescribers Among an Urban Medicaid Population with Diabetes Mellitus.

Authors:  Samina T Syed; Lisa K Sharp; Yoonsang Kim; Adam Jentleson; Claudia M Lora; Daniel R Touchette; Michael L Berbaum; Katie J Suda; Ben S Gerber
Journal:  Pharmacotherapy       Date:  2016-05-28       Impact factor: 4.705

2.  Combining use of captopril and losartan attenuates the progress of Streptococcus pneumoniae-induced tympanosclerosis through the suppression of TGF-β1 expression.

Authors:  Wenqing Yan; Jianfeng Li; Renjie Chai; Wentao Guo; Lei Xu; Yuechen Han; Xiaohui Bai; Haibo Wang
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.